Optimized glucuronidation of dual pharmacology -2 agonists/M3 antagonists for the treatment of COPD
Hilton L, Osborne R, Kenyon AS, Baldock H, Bunnage ME, Burrows J, Clarke N, Coghlan M, Entwistle D, Fairman D, Feeder N, James K, Jones RM, Laouar N, Lunn G, Marshall S, Newman SD, Patel S, Selby MD, Spence F, Stuart EF, Summerhill S, Trevethick MA, Wright KN, Yeadon M, Price DA, Jones LH
nan